A 2014 survey by the American Society of Dermatologic Surgery (ASDS) found that 68% of those surveyed were bothered by submental fullness (also known as the "double chin")! Affecting both men and women, this area has been very difficult to treat short of full cosmetic plastic surgery which often requires significant downtime, pain, and expense. Influenced by a variety of factors including genetics, aging, and weight gain, the double chin is notoriously difficult to reduce through diet and exercise; it stubbornly holds on even in otherwise slender & healthy individuals.
KYBELLA™ is the first and only FDA-approved injectable that contours and approves the appearance of moderate to severe submental fullness (also known as the "double chin"). This new injectable is made of deoxycholic acid, a naturally-occuring molecule that targets and permanently destroys the unwanted fat cells, resulting in a slimmer, younger profile.
This innovative new treatment involves a series of injections into the submental (below the chin) fat area. How many injections are needed may vary based on the size of the area to be treated. The Kybella procedure uses very fine needles, similar to BOTOX & dermal fillers, so pain and discomfort is minimal. In our office, we also use a mild local anesthesia to further minimize any discomfort. Typically, 2-4 treatments spaced about one month apart are required to achieve the desired look.
- Only FDA approved injectable to treat the double chin area
- Non-surgical procedure
- Minimal to no downtime
- Results are permanent